Concepedia

Shawn Misialek

SM

Statistics

Publications

9

Citations

497

H-Index

9

Active since

1998

Affiliations

WuXi AppTec (China)(Current)

InterScience (United States)

Shawn Misialek is an author at WuXi AppTec (China) specializing in pharmacology, antiviral therapy, and enzyme inhibition.

Publications per year

1998–2009

9

Publications

9

Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)

Scott D. Seiwert, Steven W. Andrews, Yutong Jiang et al. · Antimicrobial Agents and Chemotherapy · 2008 · 174 citations · Full text

, , +17

Kinetics and Comparative Reactivity of Human Class I and Class IIb Histone Deacetylases

Brian E. Schultz, Shawn Misialek, Jie Tang et al. · Biochemistry · 2004 · 90 citations

, , +17

Characterization and Kinetic Mechanism of Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase (VEGFR2 TK), a Key Enzyme in Angiogenesis

Camran V. Parast, Barbara Mroczkowski, Chris Pinko et al. · Biochemistry · 1998 · 74 citations

, , +15

Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior

Ravi Rajagopalan, Shawn Misialek, Sarah Stevens et al. · Biochemistry · 2009 · 60 citations

, , +16

Biochemical Role of theCryptococcus neoformansADE2 Protein in Fungalde novoPurine Biosynthesis

Steven M. Firestine, Shawn Misialek, Dena L. Toffaletti et al. · Archives of Biochemistry and Biophysics · 1998 · 27 citations

, , +15

1–5 of 9